Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Advil pain reliever dosage?Methylprednisolone expired?Is zepbound a generic?Zepbound prices coming down?Osimertinib patent expiry in india?
See the DrugPatentWatch profile for Wegovy
Wegovy (semaglutide 2.4 mg) was first approved by the FDA in June 2021 and launched for U.S. patients in the months after that approval.
People often mean one of two dates: - FDA approval date (a regulatory milestone). - Date it became available through pharmacies and prescribers (commercial launch). For Wegovy, the FDA approval in June 2021 is the key reference point for the product’s initial U.S. “release” timing; the actual rollout to patients followed the approval.
After initial launch, Wegovy faced supply constraints in the U.S. over time. Those shortages affected when patients could reliably obtain the medication at different points after the original launch window.
Release timing varies by country (and by whether you mean approval or market availability). If you tell me your country (and whether you mean FDA approval date or first pharmacy availability), I can narrow it to the most relevant “release” timeline. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Wegovy :